Galenica Expands Consumer Offering With Deal For Herbals Specialist Padma
Switerland's Galenica has bolstered its OTC offering by acquiring local player Padma and its portfolio of OTCs and supplements inspired by Tibetan medicine.
You may also be interested in...
Dietary supplement brands with sustainable and ethical credentials are expected to be popular M&A targets for consumer health firms in 2024, but macroeconomic conditions will likely keep overall deal activity relatively low.
Galenica's Verfora grows its share of the Swiss consumer health market to 10.2% as its sales jump by 14.1% in the opening six months of 2023.
Galenica's Verfora substantially outpaced the 6.4% growth rate of the Swiss consumer health market in the first half, posting sales up by a third thanks to a combination of acquisitions and increased demand for cold & flu products due to the spread of the COVID-19 Omicron variant.